Published in Blood Weekly, April 14th, 1997
A new blood test permits physicians to rapidly determine whether a patient's HIV strain is susceptible to particular anti-HIV drugs. The genotypic assay, dubbed HIV-1 GenotypR Plus, is manufactured by Specialty Laboratories Inc., Santa Monica, California.
It has been less than three months since a leading AIDS researcher expressed the hope that such a test would be available by the end of the decade.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.